Allergan reports 2Q loss

Markets Associated Press

Allergan PLC (AGN) on Thursday reported a loss of $725.9 million in its second quarter.

Continue Reading Below

On a per-share basis, the Dublin-based company said it had a loss of $2.37. Earnings, adjusted for one-time gains and costs, came to $4.02 per share.

The results surpassed Wall Street expectations. The average estimate of 17 analysts surveyed by Zacks Investment Research was for earnings of $3.95 per share.

The Botox maker posted revenue of $4.01 billion in the period, which also beat Street forecasts. Nineteen analysts surveyed by Zacks expected $3.95 billion.

Allergan expects full-year earnings in the range of $16.05 to $16.45 per share, with revenue in the range of $15.85 billion to $16.05 billion.

Allergan shares have climbed 19 percent since the beginning of the year, while the Standard & Poor's 500 index has risen 11 percent. The stock has dropped slightly in the last 12 months.

Continue Reading Below


This story was generated by Automated Insights using data from Zacks Investment Research. Access a Zacks stock report on AGN at


Keywords: Allergan, Earnings Report